Sign in
4

Changes in Ownership

HANOVER INSURANCE GROUP, INC. Filed Acc 0001062993-25-006637

President and CEO sold 701 shares at an average $175.02 ($122,687)

  • President and CEO acquired 701 shares (option exercise)
  • President and CEO acquired 135.86 shares (grant or award)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Roche John C President and CEO 2025-03-28 Option exercise 10b5-1 +400 $77.91 $31,164 124,677.85 D: show line 1 in the form
Roche John C President and CEO 2025-03-28 Sale 10b5-1 −400 $175.03 $70,012 124,277.85 D: show line 2 in the form
Roche John C President and CEO 2025-03-28 Grant or award 10b5-1 +135.86 124,413.71 D: show line 3 in the form
Roche John C President and CEO 2025-03-31 Option exercise 10b5-1 +301 $77.91 $23,451 124,714.71 D: show line 4 in the form
Roche John C President and CEO 2025-03-31 Sale 10b5-1 −301 $175.00 $52,675 124,413.71 D: show line 5 in the form
Open-market sales · 701 sh · avg $175.02 · $122,687

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Roche John C President and CEO 2025-03-28 Option exercise · Common Stock Option (right to buy) 10b5-1 −400 9,207 D: show line 6 in the form
Roche John C President and CEO 2025-03-31 Option exercise · Common Stock Option (right to buy) 10b5-1 −301 8,906 D: show line 7 in the form
Loading xslF345X05/form4.xml…